WT1-targeted immunotherapy of leukaemia
- 31 December 2004
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 33 (3) , 288-290
- https://doi.org/10.1016/j.bcmd.2004.08.018
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Acute graft-versus-host disease does not require alloantigen expression on host epitheliumNature Medicine, 2002
- Type 1 T regulatory cellsImmunological Reviews, 2001
- Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditionsBlood, 2001
- Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory BlockadeThe Journal of Experimental Medicine, 2001
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Transplantation of Anergic Histoincompatible Bone Marrow AllograftsNew England Journal of Medicine, 1999
- A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitisNature, 1997
- B-B10 (ANTI-CD25)-SAPORIN IMMUNOTOXIN—A POSSIBLE TOOL IN GRAFT-VERSUS-HOST DISEASE TREATMENTTransplantation, 1992
- Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsBlood, 1990
- Graft-versus-leukemia reactions after bone marrow transplantationBlood, 1990